Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: The prognostic implications of cognitive impairment in amyotrophic lateral sclerosis (ALS) are not established.
Objectives: To investigate the survival effect of the comorbid frontotemporal dementia (FTD) and to determine whether, in the absence of dementia, impairment in different cognitive domains affects outcome.
Methods: A prospective population-based study of incident cases of ALS in the Republic of Ireland included home-based neuropsychological assessments using age-, sex-, and education-matched controls. Four cognitive domains were evaluated: executive function, memory, language, and visuospatial skills.
Results: Mean age of the participants (n = 139) was 63.3 years; 61.2% were male and 35.3% had bulbar-onset ALS. Factors associated with shorter survival included age more than 60, severe disability at baseline, shorter delay to diagnosis, and early respiratory involvement. Comorbid FTD was associated with significantly shorter survival time (hazard ratio [HR] 2.67, 95% confidence interval [CI] 1.04–6.85, p = 0.041). In patients with ALS without dementia, the presence of executive dysfunction was significantly associated with shorter survival. This was confirmed in a multivariate model that included age, delay to diagnosis, disease severity at baseline, education, and respiratory status (HR 3.44, 95% CI 1.45–8.18, p = 0.005). In the absence of executive dysfunction, single or multi-domain impairment in other cognitive domains had no significant effect on survival.
Conclusion: Comorbid frontotemporal dementia is a negative prognostic indicator. In patients with ALS without dementia, executive dysfunction, but not impairment in other cognitive domains, is an important negative prognostic indicator.
Footnotes
-
Study funding: Supported by the ALS Association, the Health Research Board (Ireland), and Research Motor Neurone.
-
Supplemental data at www.neurology.org
-
- ALS
- amyotrophic lateral sclerosis
- ALSFRS-R
- ALS Functional Rating Scale
- CI
- confidence interval
- DSM-IV
- Diagnostic and Statistical Manual of Mental Disorders, 4th edition
- FSIQ
- full-scale IQ
- FTD
- frontotemporal dementia
- HADS
- Hospital Anxiety and Depression Scale
- HR
- hazard ratio
- NIV
- noninvasive ventilation
- SNIP
- sniff nasal inspiratory pressure
- WTAR
- Wechsler Test of Adult Reading
- Received September 16, 2010.
- Accepted December 22, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Determining the incidence of familiality in ALSA study of temporal trends in Ireland from 1994 to 2016Marie Ryan, Mark Heverin, Mark A. Doherty et al.Neurology: Genetics, May 18, 2018 -
Article
Cognitive changes predict functional decline in ALSA population-based longitudinal studyMarwa Elamin, Peter Bede, Susan Byrne et al.Neurology, April 03, 2013 -
Articles
Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIVA. Chiò, A. Ilardi, S. Cammarosano et al.Neurology, March 21, 2012 -
Article
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALSChristopher Crockford, Judith Newton, Katie Lonergan et al.Neurology, September 12, 2018